Kit Check Cofounders Tim Kress-Spatz (left) and Kevin MacDonald.
Kit Check just raised a $15 million Series C to help the team achieve its goal of streamlining the way hospitals do business with pharmacies. While not unheard of, this is a big raise by D.C. standards.
The round was led by Baxter Ventures, the venture arm of Chicago-area healthcare company Baxter, with participation from new investor Black Granite Capital and existing investors Kaiser Permanente Ventures, Rex Health Ventures, New Leaf Venture Partners, Easton Capital Investment Group, LionBird and Sands Capital Ventures. The latest raise brings the four-year-old company’s total investment to $37.4 million.
READ FULL ARTICLE HERE